» Articles » PMID: 35088806

Phagocytic Activity of Monocytes and Neutrophils in Patients with Periodontitis, Whether or Not Associated to Type 2 Diabetes

Abstract

Phagocytic functions by neutrophils/ monocytes and biochemical parameters were assessed in peripheral blood of patients with periodontitis, whether or not associated to type 2 diabetes, or patients with type 2 diabetes, or systemically healthy people. Fifty-eight participants were divided into four groups: Control - systemically and periodontally healthy patients (C, n=16), Periodontitis (P, n=14), Type 2 Diabetes (DM, n=11) and Periodontitis associated with type 2 diabetes (DMP, n=17). Blood samples were used to analyze phagocytic activity and the production of superoxide anion using optical microscopy. Significantly lower phagocytic activity of neutrophils was observed in non-opsonized samples (p = 0.008, Kruskal- Wallis) of the periodontitis group and in opsonized samples (p = 0.029, Kruskal-Wallis) of the periodontitis associated with type 2 diabetes group when these groups were compared to the healthy individuals when a 20:1 yeast: phagocyte stimulus was used. Periodontitis patients, whether associated (p = 0.0007, sensitized; Kruskal-Wallis, 20:1) or not with diabetes (p = 0.018 and 0.0007, in the proportions 5:1 and 20:1 yeast: monocyte respectively in sensitized samples; Kruskal-Wallis) also showed lower phagocytic function of monocytes compared to the control group. There was no significant difference in the production of superoxide anion among the evaluated groups. Severe clinical attachment loss was associated with lower levels of HDL in periodontitis patients and a higher percentage of A1C in diabetes with periodontitis patients (p<0.05; Pearson and Spearman correlations, respectively). Patients with both associated diseases had higher levels of triglycerides and CRP (p<0.001, Kruskal-Wallis) compared to patients with diabetes only. The results of the present study suggest that periodontitis negatively interferes with the innate immune response and may represent a major risk of systemic complications such as cardiovascular disease in diabetic patients or even in healthy individuals.

References
1.
Ridker P . Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003; 107(3):363-9. DOI: 10.1161/01.cir.0000053730.47739.3c. View

2.
Brown G . Innate antifungal immunity: the key role of phagocytes. Annu Rev Immunol. 2010; 29:1-21. PMC: 3434799. DOI: 10.1146/annurev-immunol-030409-101229. View

3.
Iwamoto Y, Nishimura F, Soga Y, Takeuchi K, Kurihara M, Takashiba S . Antimicrobial periodontal treatment decreases serum C-reactive protein, tumor necrosis factor-alpha, but not adiponectin levels in patients with chronic periodontitis. J Periodontol. 2003; 74(8):1231-6. DOI: 10.1902/jop.2003.74.8.1231. View

4.
King G . The role of inflammatory cytokines in diabetes and its complications. J Periodontol. 2008; 79(8 Suppl):1527-34. DOI: 10.1902/jop.2008.080246. View

5.
Sanz M, Ceriello A, Buysschaert M, Chapple I, Demmer R, Graziani F . Scientific evidence on the links between periodontal diseases and diabetes: Consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International diabetes Federation and the European Federation of.... Diabetes Res Clin Pract. 2017; 137:231-241. DOI: 10.1016/j.diabres.2017.12.001. View